Industry expertise, GMP-compliant manufacturing, AI-enhanced regulatory strategy, and end-to-end CDMO support — helping IVD companies accelerate commercialization with lower risk and higher efficiency.
We understand the challenges faced by IVD startups and biotechnology companies
IVDCDMO is committed to helping diagnostic innovators accelerate product commercialization through integrated CDMO solutions, regulatory expertise, and GMP-compliant manufacturing capabilities.
Proven Registration Success Experience
AI-Enhanced Regulatory Strategy
Long-Term Strategic Partnership
Whether you are developing a new diagnostic assay, scaling production, or preparing for regulatory approval, IVDCDMO serves as your long-term strategic partner throughout the entire product lifecycle.
Mr. Johnson
Our Founder
Why Choose IVDCDMO
IVDCDMO — Professional IVD CDMO Solutions for Global Diagnostic Innovation
Choosing the right CDMO partner is critical to the success of any IVD project.
One-Stop IVD CDMO Solutions
Faster Time-to-Market
Global Regulatory Expertise
Flexible Manufacturing
Experienced Technical Team
Reliable Quality Management
Cost-Effective Partnership
At IVDCDMO, we combine industry expertise, compliant manufacturing, regulatory knowledge, and commercialization experience to help diagnostic companies move from concept to market with greater speed, confidence, and efficiency.
Monoclonal & Polyclonal Antibody Preparation generates high-specificity binders for IVD, with custom antibody development optimized for multiple diagnostic immunoassay formats.
ELISA is a widely used technique for detecting and quantifying proteins, hormones, antibodies, and other antigens. Our antibodies are optimized for high-performance ELISA development.
Chemiluminescence immunoassay (CLIA) offers the highest sensitivity among immunoassay formats, with detection limits in the femtogram/mL range. Our antibodies are optimized for CLIA systems.